Modulation of plasma cyst(e)ine by cisplatin

Area of Science:

• Oncology
• Biochemistry
• Pharmacology

Background:

• Certain human malignant cells exhibit cyst(e)ine auxotrophy, meaning they require external cyst(e)ine for growth.
• Understanding the metabolic impact of chemotherapy is crucial for optimizing cancer treatment strategies.

Purpose of the Study:

• To investigate the effect of cisplatin treatment on plasma cyst(e)ine levels in cancer patients.
• To determine if cisplatin-induced cyst(e)ine depletion impacts cancer cell proliferation.

Main Methods:

• Eight cancer patients received 10 courses of cisplatin treatment.
• Plasma cyst(e)ine concentrations were measured before and 6 hours after cisplatin infusion.
• Correlation between plasma cisplatin concentration and cyst(e)ine decrease was analyzed.
• In vitro proliferation assays using human promyelocytic (HL-60) cells were conducted.

Main Results:

• Cisplatin treatment resulted in a mean 83% decrease in plasma cyst(e)ine levels.
• The magnitude of cyst(e)ine reduction correlated with peak plasma cisplatin concentrations.
• Post-treatment plasma cyst(e)ine levels (mean 9 microM) were low enough to inhibit HL-60 cell proliferation in culture.

Conclusions:

• Cisplatin effectively depletes plasma cyst(e)ine in cancer patients.
• This depletion may represent a significant mechanism by which cisplatin exerts its anti-cancer effects, particularly against cyst(e)ine-auxotrophic tumors.
• Further research into cyst(e)ine modulation during chemotherapy is warranted.